Speeches & Communication

PhRMA Comments on BsUFA

PhRMA February 10, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to have the opportunity to respond to the Food and Drug Administration’s (FDA) request for comments on the overall performance of the Biosimilar User Fee Act (BsUFA) and to participate in the upcoming reauthorization of BsUFA (BsUFA II). PhRMA is a voluntary, nonprofit association that represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives. PhRMA’s membership includes several leading biopharmaceutical companies actively developing biosimilar medicines and working with the Food and Drug Administration (FDA) to bring these to patients.